| Breakdown | Mar 2026 | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 5.32T | 4.75T | 4.40T | 3.98T | 3.11T |
| Gross Profit | 1.78T | 1.63T | 1.51T | 1.33T | 1.06T |
| EBITDA | 732.88B | 665.14B | 645.76B | 559.26B | 464.41B |
| Net Income | 291.83B | 264.76B | 260.31B | 257.75B | 217.71B |
Balance Sheet | |||||
| Total Assets | 5.83T | 5.13T | 4.88T | 4.30T | 3.82T |
| Cash, Cash Equivalents and Short-Term Investments | 937.53B | 802.66B | 737.96B | 617.66B | 817.62B |
| Total Debt | 1.10T | 986.85B | 968.18B | 887.63B | 824.81B |
| Total Liabilities | 2.50T | 2.27T | 2.19T | 2.02T | 1.82T |
| Stockholders Equity | 3.27T | 2.81T | 2.64T | 2.24T | 1.97T |
Cash Flow | |||||
| Free Cash Flow | 272.25B | 268.46B | 156.93B | -16.18B | 130.97B |
| Operating Cash Flow | 493.94B | 514.45B | 399.57B | 158.90B | 245.07B |
| Investing Cash Flow | -336.99B | -337.41B | -227.19B | -229.79B | -180.79B |
| Financing Cash Flow | -170.49B | -153.47B | -129.62B | -113.09B | -48.70B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
82 Outperform | $103.14B | 39.77 | 34.71% | 0.95% | 6.36% | 7.42% | |
75 Outperform | $44.21B | 19.05 | 9.01% | 1.29% | 6.74% | 5.42% | |
72 Outperform | $87.30B | 32.41 | 25.46% | 1.27% | -0.60% | 49.11% | |
71 Outperform | $17.45B | 34.45 | 72.05% | 0.96% | -2.03% | -1.09% | |
69 Neutral | $53.71B | 49.39 | 9.34% | 1.65% | -5.07% | -65.16% | |
66 Neutral | $13.39B | 26.65 | 38.36% | 1.28% | -0.53% | -1.29% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% |